Initial clinical outcomes of two different phakic posterior chamber IOLs for the correction of myopia and myopic astigmatism.
ICL
IPCL
Implantable contact lens
Visian implantable collamer lens
Journal
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
12
08
2021
accepted:
15
10
2021
revised:
04
10
2021
pubmed:
7
11
2021
medline:
16
4
2022
entrez:
6
11
2021
Statut:
ppublish
Résumé
The purpose of this study is to document clinical outcomes of 2 posterior chamber phakic intraocular lenses with a central hole, the implantable contact lens (IPCL V2.0) and the Visian implantable collamer lens V4c (ICL), in myopic and myopic-astigmatic patients. Retrospective study comprising 111 IPCL (60 toric) and 106 ICL implantations (59 toric) with a follow-up of 3 months to 2 years. Primary outcome was uncorrected distance visual acuity (UDVA) improvement; secondary outcomes were changes in corrected distance visual acuity (CDVA), and complications. At 3 months postoperatively, 76% of plano targeted eyes in the IPCL group and 83% of eyes in the ICL group had a UDVA of 20/20 or better. Ninety-six percent of IPCL implanted eyes and 94% of ICL implanted eyes had a postoperative UDVA within 1 line of preoperative CDVA. One eye lost one line of CDVA after IPCL implantation, and no lines were lost after ICL implantation; 33.7% of IPCL eyes and 40.6% of ICL eyes gained at least 1 line of CDVA. Cataract extraction (none because of anterior subcapsular opacification) was performed after 4 ICL implantations, none after IPCL implantation. Endothelial cell loss was mild with both pIOLs. Mean IOP was not clinically significantly affected at 3 months or thereafter. We observed equally excellent (statistically not different) results with the IPCL and ICL for the correction of myopia and myopic astigmatism, at least up to 2 years post implantation. Longer follow-up is needed to determine the stability of these results especially with the IPCL.
Identifiants
pubmed: 34741659
doi: 10.1007/s00417-021-05465-w
pii: 10.1007/s00417-021-05465-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1763-1772Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Vukich JA, Duehr D, Sanders DR et al (2003) U.S. food and drug administration clinical trial of the implantable contact lens for moderate to high myopia. Ophthalmology 110(2):255–266. https://doi.org/10.1016/S0161-6420(02)01771-2
doi: 10.1016/S0161-6420(02)01771-2
Sandrs DR, Doney K, Poco M (2004) United States Food and Drug Administration clinical trial of the implantable collamer lens (ICL) for moderate to high myopia: three-year follow-up. Ophthalmology 111(9):1683–1692. https://doi.org/10.1016/j.ophtha.2004.03.026
doi: 10.1016/j.ophtha.2004.03.026
Huang D, Schallhorn SC, Sugar A et al (2009) Phakic intraocular lens implantation for the correction of myopia: a report by the American Academy of Ophthalmology. Ophthalmology 116(11):2244–2258. https://doi.org/10.1016/j.ophtha.2009.08.018
doi: 10.1016/j.ophtha.2009.08.018
Pineda-Fernández A, Jaramillo J, Vargas J et al (2004) Phakic posterior chamber intraocular lens for high myopia. J Cataract Refract Surg 30(11):2277–2283. https://doi.org/10.1016/j.jcrs.2004.03.035
doi: 10.1016/j.jcrs.2004.03.035
Sachdev G, Ramamurthy D (2019) Long-term safety of posterior chamber implantable phakic contact lens for the correction of myopia. Clin Ophthalmol 13:137–142. https://doi.org/10.2147/OPTH.S185304
doi: 10.2147/OPTH.S185304
Taneri S, Kießler S, Rost A et al (2018) Atypical endophthalmitis after intraocular collamer lens implantation. J Cataract Refract Surg 44(12):1521–1523. https://doi.org/10.1016/j.jcrs.2018.08.010
Packer M (2018) The implantable collamer lens with a central port: review of the literature. Clin Ophthalmol 12:2427–2438. https://doi.org/10.2147/OPTH.S188785
doi: 10.2147/OPTH.S188785
Gonzalez-Lopez F, Bilbao-Calabuig R, Alen R et al (2017) Pupillary block glaucoma secondary to central port occlusion following insertion of a phakic implantable copolymer lens. J Cataract Refract Surg 43(11):1468–1470. https://doi.org/10.1016/j.jcrs.2017.10.018
doi: 10.1016/j.jcrs.2017.10.018
Tychsen L, Faron N, Hoekel J (2017) Phakic intraocular collamer lens (Visian ICL) implantation for correction of myopia in spectacle-aversive special needs children. Am J Ophthalmol 175:77–86. https://doi.org/10.1016/j.ajo.2016.11.016
doi: 10.1016/j.ajo.2016.11.016
Martín-Escuer B, Alfonso JF, Esteve-Taboada JJ et al (2017) Implantation of implantable collamer lenses after radial keratotomy. J Refract Surg 33(6):395–398. https://doi.org/10.3928/1081597X-20170426-01
doi: 10.3928/1081597X-20170426-01
Igarashi A, Shimizu K, Kamiya K (2014) Eight-year follow-up of posterior chamber phakic intraocular lens implantation for moderate to high myopia. Am J Ophthalmol 157(3):532–9.e1. https://doi.org/10.1016/j.ajo.2013.11.006
Alfonso JF, Baamonde B, Fernández-Vega L et al (2011) Posterior chamber collagen copolymer phakic intraocular lenses to correct myopia: five-year follow-up. J Cataract Refract Surg 37(5):873–880. https://doi.org/10.1016/j.jcrs.2010.11.040
doi: 10.1016/j.jcrs.2010.11.040
Vasavada V, Srivastava S, Vasavada SA et al (2018) Safety and efficacy of a new phakic posterior chamber IOL for correction of myopia: 3 years of follow-up. J Refract Surg 34(12):817–823. https://doi.org/10.3928/1081597X-20181105-01
doi: 10.3928/1081597X-20181105-01
Yaşa D, Ürdem U, Ağca A et al (2018) Early results with a new posterior chamber phakic intraocular lens in patients with high myopia. J Ophthalmol 2018:1–8. https://doi.org/10.1155/2018/1329874
doi: 10.1155/2018/1329874
Sheetal B, Gautam MM, Snehal Sute MS et al (2021) Visual and refractive outcomes with the eyecryl phakic toric IOL versus the Visian toric implantable collamer lens: results of a 2-year prospective comparative study. J Refract Surg 37(1):7–15. https://doi.org/10.3928/1081597X-20201013-04
Bianchi GR (2020) Presbyopia management with diffractive phakic posterior chamber IOL. Cesk Slov Oftalmol 76(5):211–219. https://doi.org/10.31348/2020/30
doi: 10.31348/2020/30
Schmid R, Luedtke H (2020) A novel concept of correcting presbyopia: first clinical results with a phakic diffractive intraocular lens. Clin Ophthalmol 14:2011–2019. https://doi.org/10.2147/OPTH.S255613
doi: 10.2147/OPTH.S255613
Sachdev G, Singh S, Ramamurthy S et al (2019) Comparative analysis of clinical outcomes between two types of posterior chamber phakic intraocular lenses for correction of myopia and myopic astigmatism. Indian J Ophthalmol 67(7):1061–1065. https://doi.org/10.4103/ijo.IJO_1501_18
doi: 10.4103/ijo.IJO_1501_18
Gonzalez-Lopez F, Bouza-Miguens C, Tejerina V et al (2021) Long-term assessment of crystalline lens transparency in eyes implanted with a central-hole phakic collamer lens developing low postoperative vault. J Cataract Refract Surg 47(2):204–210. https://doi.org/10.1097/j.jcrs.0000000000000425
doi: 10.1097/j.jcrs.0000000000000425